earnings
confidence high
sentiment positive
materiality 0.75
LifeStance Q1 revenue $333M (+11%), first positive net income as public company
LifeStance Health Group, Inc.
- Revenue $333M (+11% YoY); net income $0.7M vs net loss $21.1M in Q1 2024.
- Adjusted EBITDA $34.6M (+25% YoY); Center Margin $109.8M (33.0% of revenue).
- Clinician base grew to 7,535 (+10% YoY); visit volumes 2.1M (+10%).
- FY 2025 guidance reaffirmed: revenue $1.40B-$1.44B, Adj EBITDA $130M-$150M.
- Q2 2025 guidance: revenue $332M-$352M, Adj EBITDA $28M-$34M.